Unsaturated Polyester Resin Market To Represent USD 11.37 Billion Opportunity Globally by 2020

Global Unsaturated Polyester Resin (UPR) Market is expected to reach USD 11.37 billion by 2020, according to a new study by Grand View Research, Inc. Growing construction industry as a result of industrialization in emerging countries including China, India and Brazil is expected to increase Fiberglass Reinforced Plastics (FRP) demand. UPR is extensively used in the manufacturing of FRP and is expected to witness growth on account of growing FRP use in construction. Increasing use of tanks & pipes in the chemical industry is expected to propel UPR demand over the forecast period.

Building & construction was the most dominant end-use of UPR with demand estimated at over 1,100.0 kilo tons in 2013 owing to increasing FRP usage. Increasing application scope in industries including marine, aerospace, automotive and chemical is expected to result in high demand for UPR over the next six years. UPR use in tanks and pipe is expected to be a key area of development for the market over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/unsaturated-polyester-resin-upr-market

Further key findings from the study suggest:

  • Global UPR demand was estimated at 4,509.3 kilo tons in 2013 and is expected to exceed 6,800.0 kilo tons by 2020, growing at a CAGR of 6.3% from 2014 to 2020.
  • Orthopthalic resins are widely used in transport, construction and marine industries owing to low cost as compared to DCPD resins. However, the latter are increasingly gaining acceptance due to low VOC emissions and are estimated to gain share over the next six years. DCPD resins are expected to witness fastest growth at an estimated CAGR of 6.7% from 2014 to 2020.
  • Construction industry is expected to witness high UPR demand primarily due to lightweight and high sustainability of FRP. Increased infrastructure spending by emerging countries is expected to positively impact UPR demand.
  • Asia Pacific accounted for more than 50% of market volume share in 2013 owing to high end-use industry growth. Emerging economies of India and China are experiencing rapid industrialization resulting in infrastructure improvement and increased marine, transport, aerospace and automobile industries which are key factors responsible for high market share.
  • UPR market has numerous domestic participants catering to end-use industries in their respective region. The market is fragmented on a global level with the top four companies accounting for less than 25% of the market in 2013. Key global participants in the market include BASF, Dow Chemicals, Ashland and CCP Composites.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

For the purpose of this study, Grand View Research has segmented the global UPR market on the basis of product, end-use and region:

UPR Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2020)
• Orthopthalic
• Isopthalic
• DCPD
• Others
UPR End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2020)
• Building & Construction
• Tanks & Pipes
• Electrical
• Marine
• Transport
• Artificial Stones
• Others
UPR Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2020)
• North America
• Europe
• Asia Pacific
• RoW

Access press release of this report – http://www.grandviewresearch.com/press-release/global-unsaturated-polyester-resin-upr-market

 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information Visit – http://www.grandviewresearch.com/

Urinalysis Market Will Grow Rapidly Based In Increasing Prevalence Of Diabetes Till 2022: Grand View Research, Inc.

Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.

Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.

The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.

The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/urinalysis-market

Further key findings from the study suggest:

  • Urinary Tract Infections (UTIs)dominated the application segment in 2014. The foremost factor responsible for its high share is the rising prevalence of UTIs, especially in females. However, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
  • Consumables held the largest share with revenue generation of over USD 1 million in 2014. The increasing usage of test strips and reagents for urinalysisis one of the major factors that are attributed to its large market share. However, the instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment’s growth.
  • The home healthcare segment, on the other hand, is anticipated to grow at a substantial rate over 7.5%. The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
  • North America dominated the overall urinalysis market with a revenue generation of over USD 540 million in 2014. The introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending in this region are the key factors attributing to the largest market share of this region.
  • Key players of this market include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex.
  • Market participants are constantly engaged in the introduction of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, in June 2014, Roche launched a fully automated urine testing analyzer named Cobas 6500 with an objective to enhance staff safety and increase the result reliability.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global urinalysis market on the basis of product, application, end-use, and region:

Global Urinalysis Product Outlook (Revenue, USD Million, 2015 – 2022)

  • Instruments
    • Biochemical urine analyzers
      • Automated biochemical analyzers
      • Semi-automated biochemical analyzers
    • Automated urine sediment analyzers
      • Microscopic urine analyzers
      • Flow-cytometric urine analyzers
    • Consumables
      • Dipsticks
      • Reagents
      • Disposables

Global Urinalysis Application Outlook (Revenue, USD Million, 2015 – 2022)

  • UTIs
  • Diabetes
  • Kidney Disease
  • Hypertension
  • Liver disease
  • Others

Global Urinalysis End-use Outlook (Revenue, USD Million, 2015 – 2022)

  • Hospitals
  • Clinical Laboratories
  • Home healthcare
  • Research and academics
  • Others

Urinalysis Regional Outlook (Revenue, USD Million, 2015 – 2022)

  • North America
    • S.
    • Canada
  • Europe
    • K
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-urinalysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

 

Vaccine Market To Gain From Rising Demand For Better Healthcare Infrastructure System Till 2024: Grand View Research, Inc.

The global vaccine market is expected to reach over USD 77.5 billion by 2024, according to a new report by Grand View Research, Inc. The presence of numerous molecules in the pipeline is anticipated to meet the demand for efficient vaccines. These include vaccines for chest infection, tuberculosis, malaria, and dengue. Most of the key players are actively leveraging on their vaccine development technologies to launch novel preventative solutions with an objective to increase their market share. For instance, Pfizer, Inc. is involved in the development of vaccines to prevent severe infections caused by Meningococcal B, Clostridium difficile, and Staphylococcus aureus.

Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate the market growth.

For instance, the ‘Immunize Australia Program’ sponsors the immunization of individuals, which acts as a preventative action in preventing disease occurrence and checks rampant disease transmission thus protecting millions of Australians from severe diseases. Another program that has been involved in achieving extensive immunization coverage on the Indian continent is the National Immunization Program, a government program that has focused on taking strong preventive measures to offset vaccine-preventable diseases, particularly in children.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/vaccine-market

Further key findings from the study suggest:

  • The inactivated vaccine type segment was estimated to have over 14.5% market share in 2015 owing to the related advantages including easy storage and transport due to the highly stable nature of these vaccines. In December 2015, Sanofi Pasteur, Inc. launched a new trivalent, inactivated polio vaccine in India.
  • The DNA vaccine segment is presumed to be the fastest growing type over the forecast period owing to the ease of production compared to the cell-based vaccines and the promising, targeted immunization outcomes coupled with the continual developments in the biotechnology area. Other advantages associated are ease of production, long lasting immunogenicity, and no risk of reversion.
  • The cancer application segment is expected to witness the fastest growth with a CAGR of over 11.8% in the vaccinations market majorly attributable to the need for immunization against cancer coupled with the increasing prevalence of various types of cancer, such as cervical and colorectal cancers.
  • North America dominated the market in terms of revenue with over USD 12 billion in 2015, due mainly to the presence of extensive research and development activities and the existence of key participants of the industry in this region
  • Asia Pacific is identified to witness a lucrative growth with a CAGR of around 10.7% during the forecast period due to the growing population base and the increasing economic growth of countries, such as China, Japan, and India. Moreover, the availability of skilled labors at a lower cost and the low manufacturing operations cost provide a platform for clinical trial outsourcing of the vaccinations under development to expedite commercialization.
  • Leading players in this industry, among others are, Merck & Co., Inc., Emergent BioSolutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., and GlaxoSmithKline Plc. Other prominent players include Abbott Laboratories, Inc., AstraZeneca plc, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals International, Inc.
  • In April 2016, VBI vaccines, Inc. entered into a collaborative agreement with Sanofi Pasteur, Inc. to employ its “Lipid Particle Vaccine” formulation technology to better the stability of the Sanofi vaccines.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global vaccines market on the basis of type, application, and region:

Global Vaccines Market By Type (Revenue, USD Million, 2013 – 2024)

  • Inactivated vaccines
  • DNA vaccines
  • Attenuated vaccines
  • Subunit vaccines
  • Conjugate vaccines
  • Toxoid vaccines
  • Others

Global Vaccines Market By Application (Revenue, USD Million, 2013 – 2024)

  • Infectious diseases
  • Cancer
  • Autism
  • Allergy
  • Others

Vaccines Market By Region (Revenue, USD Million, 2013 – 2024)

  • North America
    • S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-vaccine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

 

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

For more information visit – http://www.grandviewresearch.com/

 

 

Vascular Closure Devices Market Size To Represent USD 1.3 Billion Opportunity Globally by 2024: Grand View Research, Inc.

Global vascular closure devices (VCDs) market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period.

Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/vascular-closure-device-vcd-market

Further Key Findings from the Study Suggest:

  • VCDs offer three types of products, which includes active approximators, passive approximators, and external hemostatic devices. Out of all three, active approximators dominated the market in 2015 as they shorten the time to ambulation and possess high efficiency rate.
  • Amongst the different end-users of VCDs, acute care facilities accounted for the largest share and are expected to maintain their dominant position over the forecast period. This is attributed to the rising popularity of VCDs in acute care treatment facilities.
  • Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of unmet demands by the hospitals and rising R&D investment in this region.
  • Some key players operating in this industry include Cardinal Health; Abbott Laboratories; COOK; Medtronic; W L. Gore & Associates; Boston Scientific Corporation; Biotronik GMBH & CO.KG; TZ Medical, Inc.; C. R. Bard, Inc.; ST. JUDE MEDICAL; Cardiva Medical, Inc.; Merit Medical Systems, Inc.; ESSENTIAL MEDICAL, INC; and Scion BioMedical.
  • This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. These prominent players are opting for different strategies to boost their status in this market. Companies are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical.
  • For instance, in October 2015, Cardinal Health acquired Johnson & Johnson’s Cordis business. Cordis is a leader in manufacturing and marketing of cardiology and endovascular devices. This acquisition was intended to expand Cardinal’s VCD product catalog to reinforce its status in the market.
  • North America dominated the market in 2015, with over 33% of total revenue. The presence of key players in this region, which are primarily involved in marketing and development of innovative VCDs, to facilitate cardiac surgeries can be attributed to the largest share of North America. Demand of products for monitoring of coronary artery disease is also expected to drive growth.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented vascular closure devices market on the basis of product, end use, and region:

Global Vascular Closure Devices Outlook, by Product (Revenue, USD Million, 2013 – 2024)

  • Active Approximators
    • Suture-based Devices
    • Clip-based Devices
  • Passive Approximators
    • Collagen Plugs
    • Sealant- or Gel-based Devices
    • Compression-Assist Devices
  • External Hemostatic Devices

Global Vascular Closure Devices Outlook, by End Use (Revenue, USD Million, 2013 – 2024)

  • Acute Care Facilities
  • Hospitals
  • Clinics

Global Vascular Closure Devices Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Peru
    • Venezuela
    • Ecuador
    • Panama
    • Costa Rica
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

 

Vein Illuminator Market Was Valued At USD 33.6 Million In 2015 And Is Expected To Reach $358.5 Million By 2024: Grand View Research, Inc.

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.

The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Vein Illuminator Market, by End-user, 2013 – 2024 (USD Million)

 Vein Illuminator Market

Further key findings from the study suggest:

  • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.
  • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.
  • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.
  • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application:

Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 – 2024)

  • Transillumination
  • Infrared technology
  • Others

Vein Illuminator Application Outlook (Revenue, USD Million, 2013 – 2024)

  • Intravenous access
  • Blood draw
  • Others

Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 – 2024)

  • Hospitals
  • Blood donation camps
  • Academic institutions
  • Others

Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access press release of this report – http://www.grandviewresearch.com/press-release/global-vein-illuminator-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Smartwatches Market

A smartwatch is a wrist-worn wearable device, and provides functionalities far beyond those of a traditional wristwatch. They are usually used as a companion device and need to be paired with a smartphone through Bluetooth and near-field communication (NFC) among other technologies. The global market was estimated to be valued at USD 702.5 million in 2013, with shipments in the same year amounting to a little over 2 million units. A well-designed smartwatch can be used as an extension to a smartphone or related device; additionally, since the focus is on apps, the high degree of connectivity provided proves useful to end users. Smartwatches are particularly useful for health-conscious users aiming for fitness tracking and health related purposes.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/smartwatches-market

Global smartphone shipments are expected to continue increasing over the next six years, giving impetus to the smartwatches market. While there are numerous features announced in smartwatch releases, fitness remains the focal point of development. For example, in 2014, Google announced its new smartwatch, which is targeted at delivering real-time speed, time and distance information when the user is on a walk or run. Android has been dominating the industry in terms of operating system used, primarily due to sales of Samsung’s smartwatches. Google also announced Android Wear, an operating system designed for wearable devices, and is working with companies including Motorola, LG, Samsung, HTC and Asus among others. Other operating systems include Pebble OS, which is a FreeRTOS used by U.S. based Pebble.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

High-end smartwatches accounted for approximately 90% of the overall market share in 2013. While growing demand for wearable technology and the entry of a considerable number of established players are expected to drive the market, unwillingness to pay between USD 250 and USD 300 for a smartwatch due to the lack of a compelling value proposition is a concern. Limited battery life is expected to be a restraint for market growth, with a tradeoff between the battery life and overall performance. Privacy concerns among users may also inhibit acceptance; this is mainly because user-related data and statistics are available on the cloud, and may be misused. Average selling price of smartwatches is expected to steadily decline, mainly due to the expected number of market entrants. While the market is presently overrun with companies offering high-end products at premium prices, growing R&D and commercialization activities is expected to result in a significant number of mid-priced and low-end products over the forecast period.

Access press release of this report – http://www.grandviewresearch.com/press-release/global-smartwatches-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

A smartwatch is a wrist-worn wearable device, and provides functionalities far beyond those of a traditional wristwatch. They are usually used as a companion device and need to be paired with a smartphone through Bluetooth and near-field communication (NFC) among other technologies. The global market was estimated to be valued at USD 702.5 million in 2013, with shipments in the same year amounting to a little over 2 million units. A well-designed smartwatch can be used as an extension to a smartphone or related device; additionally, since the focus is on apps, the high degree of connectivity provided proves useful to end users. Smartwatches are particularly useful for health-conscious users aiming for fitness tracking and health related purposes.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/smartwatches-market

Global Smartwatches Market, by Region, 2013

smartwatches-market

Global smartphone shipments are expected to continue increasing over the next six years, giving impetus to the smartwatches market. While there are numerous features announced in smartwatch releases, fitness remains the focal point of development. For example, in 2014, Google announced its new smartwatch, which is targeted at delivering real-time speed, time and distance information when the user is on a walk or run. Android has been dominating the industry in terms of operating system used, primarily due to sales of Samsung’s smartwatches. Google also announced Android Wear, an operating system designed for wearable devices, and is working with companies including Motorola, LG, Samsung, HTC and Asus among others. Other operating systems include Pebble OS, which is a FreeRTOS used by U.S. based Pebble.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

High-end smartwatches accounted for approximately 90% of the overall market share in 2013. While growing demand for wearable technology and the entry of a considerable number of established players are expected to drive the market, unwillingness to pay between USD 250 and USD 300 for a smartwatch due to the lack of a compelling value proposition is a concern. Limited battery life is expected to be a restraint for market growth, with a tradeoff between the battery life and overall performance. Privacy concerns among users may also inhibit acceptance; this is mainly because user-related data and statistics are available on the cloud, and may be misused. Average selling price of smartwatches is expected to steadily decline, mainly due to the expected number of market entrants. While the market is presently overrun with companies offering high-end products at premium prices, growing R&D and commercialization activities is expected to result in a significant number of mid-priced and low-end products over the forecast period.

Access press release of this report – http://www.grandviewresearch.com/press-release/global-smartwatches-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Smartwatches Market

U.S. In Vitro Diagnostics And Laboratory Developed Tests For Autoimmune Diseases Market Forecast, Industry Outlook, Share 2016 To 2024

The U.S. IVD for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach a value of USD 4.74 billion by 2024 .The U.S. Laboratory Developed Test (LDT) for autoimmune diseases was valued at USD 830.9 million in 2015. The high prevalence of autoimmune disorders, growing awareness about these ailments, growing demand for technologically developed & high performance products, and high investments in research are the driving factors for the expanding growth of the market.

These health problems are second leading cause of chronic illness in the U.S. and are amongst the leading causes of deaths in the U.S. women. They have an adverse impact on the work productivity and the quality of life of patients and form an economic burden greatly affecting the healthcare spending in the U.S. The National Institute of Health estimates the direct healthcare costs associated with these disorders accounted for around USD 100 billion, whereas the cancer costs accounted for USD 57 billion.

A large number of people suffering from these disorders and rising prevalence at an alarming rate resulting in an increase of healthcare spending in the U.S. are all priority concerns, and is thus are expected to drive growth. Furthermore, the complications resulting from such health hazards like damage to internal organs, loss of mobility, and risk of death make it crucial for early diagnosis and intervention of such conditions. The rising awareness about these conditions is expected to lead market growth.

It is believed by number of researchers that the increase in the number of autoimmune diseases globally is due to the genetic predisposition and environmental factors. But there is very little knowledge about what exactly in the environment triggers the occurrence of autoimmune diseases. and mainly focused on commercial kits that are widely used by laboratories.

The FDA regulates IVD as medical devices however in the past it did not use its authority to regulate LDT. The FDA later announced that it would enforce its medical device regulatory authority to regulate the LDTs. Some researchers believe that the FDA regulation on LDTs would lead to an increase in the time and cost required to develop the tests.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/us-in-vitro-diagnostics-ivd-laboratory-developed-tests-ldt-autoimmune-diseases-market

Further Key Findings from the Study Suggest:

  • In 2015, the IVD for rheumatoid arthritis was the leading segment with a revenue share of 14.05% and the LDT for rheumatoid arthritis had a share of 13.2%. The large number of diagnostic tests available for it as well as the high prevalence of the disease contributed to the market share.
  • In 2015, clinical chemistry was the leading segment with a market share of 35.6% in the IVD and 34.1% in the LDT. The diagnosis of autoantibodies in the blood is the most commonly employed diagnosis, thus contributing to the large share.
  • Some key participants in this field include Becton, Dickinson and Company; Roche Diagnostics; Abbott Laboratories; Bio-Rad Laboratories, Inc.; Danaher Corporation; SQI Diagnostics; Omega Diagnostics Group PLC; ThermoFisher Scientific, Inc.; and some others. The key players focus specially on developing innovative solutions for diagnosis. The laboratories and institutes such as Mayo Medical Laboratories, Oklahoma Medical Research Foundation, and Moleculera Labs also operate in the U.S. in the same domain.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics  

Grand View Research has segmented the U.S. IVD and LDT for autoimmune diseases market by application and technology:

U.S. IVD and LDT for Autoimmune Diseases Market: Application Outlook (Market Revenue in USD Billion, 2013 – 2024)

  • Addison’s Disease
  • Ankylosing Spondylitis
  • Alopecia Areata
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Psoriasis
  • Antiphospholipid Antibody Syndrome
  • Diabetes Type 1
  • Crohn’s Disease
  • Ulcerative Colitis
  • Narcolepsy
  • Multiple Sclerosis
  • Uveitis
  • Others

U.S. IVD and LDT for Autoimmune Diseases Market: Technology Outlook (Market Revenue in USD Billion, 2013 – 2024)

  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Coagulation
  • Microbiology
  • Molecular Diagnostics

Access press release of this report – http://www.grandviewresearch.com/press-release/us-in-vitro-diagnostics-ivd-laboratory-developed-tests-ldt-autoimmune-diseases-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

 

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

For more information visit – http://www.grandviewresearch.com/

U.S. Medical Device Outsourcing Market To Witness Growth Based On Increasing Incidence Rate Of Cardiovascular Diseases Till 2022: Grand View Research, Inc.

The U.S. medical device outsourcing market is expected to reach USD27.8billion by 2022, according to a new report by Grand View Research Inc. Increasing geriatric population base, surgical procedures and demand for cost curbing tools are some key growth drivers for the U.S. medical device outsourcing market.

The medical device industry has become competitive and categories such as coronary stents, orthopedic devices, and wound care are moving towards maturity. As high-impact scientific innovation in the above categories is difficult to identify, smaller companies are gaining market share by offering low prices and introducing innovative business models.

Due to the convergence of mounting challenges and changing market dynamics, many medical device manufacturers have opted for outsourcing business models to reduce cost, manage business risks, and improve service delivery. All the aforementioned facts are hence expected to propel market growth over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/us-medical-device-outsourcing-market

Further key findings from the report suggest:

  • Class II medical devices are expected to dominate the overall market throughout the forecast period, with revenue share estimated at over 48.0% in 2022. Relatively lower associated risk levels compared to class III devices coupled with increasing demand for self care equipment such as powered wheelchairs, infusion pumps etc. are expected to boost the segment growth over the forecast period.
  • Class II medical devices are outsourced for designing, manufacturing, sales and marketing, clinical and advisory services, and after sales services. Maximum numbers of medical equipment fall into this category and they are outsourced due to the requirement of special skilled personnel, cost-effectiveness, and in order to reduce the time to market these equipment.
  • Product design and development was the largest service segment, with revenue share valued at 28.6% in 2014. This dominance is attributed to associate benefits to companies such as aid in innovative product development. Also, the expertise provided by the outsourcing partners, help reduce costs and product development duration, pilot testing, and commercialization.
  • Key players of this market include Active Implants Corporation LLC, Accellent Inc., MDMI Technologies Inc., Avail Medical Products Omnica Corporation, Kinetics Climax, Inc, and Teleflex Medical OEM.
  • Market participants are striving to gain competitive advantage by providing products and services across broader portfolio such as cardiac rhythm management, cardiac surgery, orthopedics and endoscopy.
  • For Example, in March 2015 Teleflex Medical OEM added balloon catheter manufacturing technology to its portfolio of in-house capabilities. New product offerings include compliant, semi-compliant and non-compliant medical balloons for a variety of coronary, peripheral and neurovascular applications.
  • Expansion of distribution network across North America, is also likely to support key players increase market penetration

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the U.S. medical device outsourcing market on the basis of application and service:

U.S. Medical Device Outsourcing Application Outlook (Revenue, USD Million, 2012 – 2022)

  • Class I
  • Class II
  • Class III

U.S. Medical Device Outsourcing Services Outlook (Revenue, USD Million, 2012 – 2022)

  • Regulatory Consulting
  • Product Design and Development
  • Product Testing
  • Product Implementation
  • Product Upgrade
  • Product Maintenance

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Tunable Diode Laser Analyzer Market Was Valued At USD 367.2 Million In 2015 And Is Expected To Reach $831.7 Million By 2024: Grand View Research, Inc.

The global tunable diode laser analyzer market size is expected to reach USD 831.7 million by 2024, according to a new report by Grand View Research, Inc. The bullish growth prospects of the tunable diode laser analyzer market can be attributed to the rapid industrialization and an increasing need for real-time and efficient atmospheric toxic gas measurement and analysis.

Favorable initiatives and regulations by the government and regulatory bodies worldwide regarding industrial emissions across various industry sectors are anticipated to bolster the market growth over the forecast period. Advanced TDL based analyzers have the ability to detect and measure toxic gases such as oxides of carbon, nitrogen, and sulfur along with oxygen and water in very low air density environments accurately. The adoption of TDLAs involves low maintenance cost, seamless detection abilities, and stability, making them preferable over other gas detectors across the end-use industries.

However, the high costs of R&D and interoperability issues are expected to hinder the industry growth over the forecast period. The accessibility to cheaper substitute devices and methods may affect the industry growth in the coming years.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/tunable-diode-laser-analyzer-market

Further key findings from the report suggest:

  • The TDLA industry, on the basis of measurement-type, can be segmented into in-situ and others such as extractive-based measurements. The in-situ or on-site type TDLA segment accounted for nearly 65% of the global market share in 2015, owing to the ease of customization, lower cost of ownership, and the control it offers.
  • Oil & gas industrial applications contributed to approximately 25% of the overall TDLA market revenue in 2015 and are anticipated to witness a steady growth over the coming years. Such growth can be accredited to the growing demand for the detection of complex hydrocarbon gases and water across upstream, downstream, and midstream process flows across refineries and petrochemical industries.
  • The demand for TDLAs in the mining & metal industry was estimated to reach over USD 130 million by 2024, growing at a CAGR of nearly 8% over the next six years. The increasing regulations and safety norms regarding harmful emissions near mining sites are expected to drive the demand for such equipment.
  • In 2015, The Asia Pacific tunable diode laser analyzer market accounted for over 25% of the overall market share and is expected to witness a substantial growth over the next eight years. The developing economies of the region, such as India, China, and Japan, are anticipated to offer broad growth avenues for the regional industry growth, owing to the increasing industrialization and modernization of processes in industries including power generation and oil & gas, eventually leading to a surge in the adoption of TDLAs.
  • Technological and product innovations drive such a highly dynamic industry. Prominent market players include Siemens AG, ABB Ltd., Yokogawa Electric Corporation, and Endress+Hauser. Vendors are focusing on expanding their presence through inorganic growth strategies such as mergers and acquisition for portfolio enhancement and regional expansion. Moreover, manufacturers are increasingly offering after-sales support and services for their TDLA equipment through its entire lifecycle, from installation to calibration and preventive maintenance repair of the equipment.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/sensors-and-controls

Grand View Research has segmented the global tunable diode laser analyzer market on the basis of measurement-type, industrial application, and region:

Tunable Diode Laser Analyzer Measurement-Type Outlook (Revenue, USD Million, 2014 – 2024)

  • In-situ
  • Others

Tunable Diode Laser Analyzer Industrial Application Outlook (Revenue, USD Million, 2014 – 2024)

  • Power
  • Oil & Gas
  • Mining & Metal
  • Healthcare
  • Chemicals
  • Fertilizers
  • Paper & Pulp
  • Cement
  • Others

Tunable Diode Laser Analyzer Regional Outlook (Revenue, USD Million, 2014 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/